| Literature DB >> 36158363 |
Said S Alijla1,2, Fitreena A Binti Amran3,2.
Abstract
Background Postoperative pain is a significant problem encountered by patients after a surgical intervention, and there is a crucial need for effective postoperative pain control. The studies have shown that multimodal analgesia and wound infiltration are effective ways to reduce this pain and have a substantial role in the reduction of postoperative medications requirement. This study aimed to evaluate the effect of subcutaneous infiltration of bupivacaine hydrochloride and intravenous (IV) diclofenac as postoperative pain relief in adults undergoing inguinal hernia repair. Methods A single-center retrospective study included 104 patients aged 18-65 undergoing unilateral inguinal herniorrhaphy at the selected hospital. The patients were in two groups of 52 each. Group A received a 75 mg dose of IV diclofenac plus a subcutaneous injection of 10 mL of bupivacaine hydrochloride (HCl) 0.5% while Group B only received the IV diclofenac without the bupivacaine injection. The postoperative pain was assessed at one, two, three, six, and 12 hrs after the operation using the visual analog scale (VAS), which exhibited a range of pain from zero (no pain) to 10 (extreme pain). Results Of a total of 104 patients, 92% of patients were male. The patients' mean age was 36 ± 11 years, and the mean body mass index (BMI) was 22 ±3 kg/m2. American Society of Anesthesiologists physical class I was similar in both groups (90.4% versus 84.6%). Patients in Group A had significantly lower VAS pain scores at one, two, three, six, and 12 hrs after the operation and a longer emergence time than Group B (all p-values were < 0.001). Subcutaneous bupivacaine infiltration and IV diclofenac were also found to be an effective analgesic technique in open hernia repair with mesh (p-value < 0.001 for all). Conclusion Subcutaneous injection of bupivacaine combined with IV diclofenac provides superior analgesia to monotherapy intravenous diclofenac after inguinal hernia repair.Entities:
Keywords: analgesics; anesthetics; bupivacaine; diclofenac; herniorrhaphy; local anesthesia; mesh repair; postoperative pain relief
Year: 2022 PMID: 36158363 PMCID: PMC9499650 DOI: 10.7759/cureus.28312
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Descriptive characteristics of the study groups
SD = Standard Deviation, BMI = Body Mass Index, SBI = Subcutaneous Bupivacaine Infiltration, IV = Intravenous, p-value 0.05 = Significant Difference, χ2 = Chi-Square Value
* Statistically significant at p-value <0.05. ** Statistically significant at p-value <0.001
| Variable | Total n (%) or (Mean ± SD) n=104 | SBI plus IV Diclofenac Group n (%) or (Mean ± SD) n=52 (50%) | IV Diclofenac Monotherapy n (%) or (Mean ± SD) n=52(50%) | χ2 | p-Value |
| Gender | 0.07 | 0.46 | |||
| Male | 96 (92.3%) | 47 (90.4%) | 49 (94.2%) | ||
| Female | 8 (7.7%) | 5 (9.6%) | 3 (5.8%) | ||
| ASA class | 0.09 | 0.38 | |||
| I | 91 (87.5%) | 47 (90.4%) | 44 (84.6%) | ||
| II | 13 (12.5%) | 5 (9.6%) | 8 (18.4%) | ||
| Type of repair | 0.21 | 0.03* | |||
| Mesh | 81 (77.9%) | 36 (44%) | 45 (56%) | ||
| Non-mesh | 23 (22.1%) | 16 (70%) | 7 (30%) | ||
| Age (year) | 36 ± (11) | 33 ± (11) | 39 ± (11) | 0.01* | |
| BMI (kg/m2) | 22 ± (3) | 22 ± (3) | 22.5 ± (3) | 0.22 | |
| Duration of anesthesia | 66 ± (11) | 72 ± (13) | 61 ± (7) | 0.001*< | |
| Duration of surgery | 53 ± (10) | 54 ± (13) | 52 ± (7) | 0.19 | |
Figure 1Median postoperative visual analog scale scores
Median pain score among both groups
VAS = Visual Analog Scale, SBI = Subcutaneous Bupivacaine Infiltration, Q = Interquartile Range, IV = Intravenous
* Statistically significant at p-value <0.001
| Variable | Total N = 104 Median (Q1-Q2) | SBI Plus IV Diclofenac N= 52 Median (Q1-Q2) | IV Diclofenac Monotherapy N= 52 Median (Q1-Q2) | P-Value |
| VAS Score at 1 Hour | 2(2-6) | 1(0-2) | 6(3-8) | <0.001** |
| VAS Score at 2 Hour | 2(1-6) | 1(0-2) | 6(4-7) | <0.001** |
| VAS Score at 3 Hour | 2(0-5) | <1(0-2) | 5(4-6) | <0.001** |
| VAS Score at 6 Hour | 3 (0-4) | <1(0-1) | 4(4-6) | <0.001** |
| VAS Score at12 Hour | 2(0-4) | <1(0-1) | 4(3-6) | <0.001** |
| Time to First Analgesic Demand (Hour) | 6(1-12) | 12(12-12) | 1(1-2) | <0.001** |
| Morphine Equivalent Dose 0-12 hrs (mg) | 4(0-4) | <1(0-1) | 10(8-10) | <0.001** |
Mean postoperative visual analog scores in the presence of a mesh
SD = Standard Deviation, SBI = Subcutaneous Bupivacaine Infiltration, VAS = Visual Analog Scale
* Statistically significant at p-value <0.05
| Variable | Total n=81 (Mean ± SD) | Mesh repair + SBI and Diclofenac n=36 (Mean ± SD) | Mesh repair + Diclofenac monotherapy n=45 (Mean ± SD) | P-Value |
| VAS Score at 1 Hour | 3± (3) | 1± (1) | 5 ± (3) | <0.001** |
| VAS Score at 2 Hour | 3± (3) | <1 ± (1) | 5 ± (2) | <0.001** |
| VAS Score at 3 Hour | 3± (3) | <1 ± (1) | 5 ± (2) | <0.001** |
| VAS Score at 6 Hour | 3± (2) | <1 ± (1) | 4 ± (1) | <0.001** |
| VAS Score at12 Hour | 3± (3) | <1 ± (1) | 5 ± (2) | <0.001** |